KZR - Kezar Life Sciences, Inc.
6.475
0.235 3.629%
Share volume: 789
Last Updated: Wed 05 Feb 2025 12:00:04 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.19%
PREVIOUS CLOSE
CHG
CHG%
$6.24
0.24
3.77%
View ratios
| Fiscal Date | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2024-05-09 | 2024-08-13 | 2024-11-12 | |
| Assets | ||||
| Total Assets | 199.130 M | 179.921 M | 164.086 M | |
| Current Assets | 185.613 M | 167.617 M | 156.379 M | |
| Inventories | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 146.766 M | 135.906 M | 113.530 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | |
| Current Cash | 33.032 M | 28.276 M | 34.858 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 3.652 M | 3.391 M | 3.149 M | |
| Other Assets | 9.865 M | 8.913 M | 4.558 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||
| Total Liabilities and shareholders’ equity | 199.130 M | 179.921 M | 164.086 M | |
| Total liabilities | 30.009 M | 29.236 M | 30.037 M | |
| Total current liabilities | 16.161 M | 17.495 M | 20.429 M | |
| Accounts Payable | 5.059 M | 2.263 M | 3.461 M | |
| Other liabilities | 5.019 M | 4.152 M | 3.259 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | |
| Long term debt | 8.829 M | 7.589 M | 6.349 M | |
| Other liabilities | 5.019 M | 4.152 M | 3.259 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 169.121 M | 150.685 M | 134.049 M | |
| Common stock | 541.897 M | 545.038 M | 548.223 M | |
| Retained earnings | -372.421 M | -393.968 M | -414.281 M |